Company Name: Zynerba Pharmaceuticals, Inc.
Zynerba Pharmaceuticals, Inc. is a specialty pharmaceutical company. The company is engaged in the development of proprietary synthetic cannabinoid therapeutics designed for transdermal delivery. The company’s developmental pipeline includes:
- CBD Gel: Product candidate for Fragile X syndrome, osteoarthritis and refractory epilepsy
- THC Pro-Drug Patch: Product candidate for fibromyalgia and peripheral neuropathic pain
Ticker Symbol: ZYNE (NASDAQ)
Company Website: http://zynerba.com
Headquarters: Devon, PA